Xue Cao

Xue Cao

Auto-generated profile, based on publicly available information

Xue Cao

The First School of Clinical Medicine Ningxia Medical University Yinchuan Ningxia China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
HFHongli Fan
Hongli Fan
YJYonggan Ji
Yonggan Ji
YWYang Wang
Yang Wang
DLDanni Liu
Danni Liu
TWTingting Wei
Tingting Wei
ZWZhisheng Wang
Zhisheng Wang
Among the most common malignancies in humans, liver cancer ranks third in terms of mortality in the world. Seeking new anticancer drugs or adjuvant chemotherapy drugs from natural products has attracted the attention of many researchers. Lycium ruthenicum Murray (LR), a health food and traditional Chinese medicine, exerts extensive pharmacological properties, of which anthocyanins are one of the key active components. In this research, we explored the antitumor activity and autophagy regulation mechanism of anthocyanins from Lycium ruthenicum Murray (ALR) in HepG2 cells. Our results found that ALR profoundly reduced the cell viability, clone formation, migration, and invasion and promoted apoptosis and G2/M phase arrest of HepG2 cells in a dose-dependent pattern. Further studies confirmed that ALR treatment significantly increased the number of autophagic vacuoles and autophagosomes, upregulated the expression of Beclin-1, p62, LC3-II/LC3-I, and p-AMPK, and concomitantly downregulated the expression of p-mTOR. When autophagy was inhibited by 3-methyladenine (3-MA), ALR-induced proliferation inhibition, invasion, and migration capabilities, as well as apoptosis rate and G2/M phase arrest, were all reversed, and the activities of key proteins in the AMPK/mTOR pathway were all constrained. In summary, the results presented here indicate that ALR may be effective as a natural antitumor agent by activating AMPK and inhibiting the mTOR autophagy pathway in HepG2 cells.

17 July 2025 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
XCXue Cao
Xue Cao
XLXinlan Liu
Xinlan Liu
PCPing Chen
Ping Chen
TWTingting Wei
Tingting Wei
QZQingxia Zhou
Qingxia Zhou
YLYaobang Liu
Yaobang Liu